InvestorsHub Logo

Ecomike

10/14/20 5:45 PM

#17172 RE: ChaseDog31 #17163

Indeed "A $110 million market cap is peanuts for a pharmaceutical company with cutting edge technology and heavy hitters running the show.

And don't forget about Kester and all of his fresh cutting edge tech that targets tumors, etc.


I am jacked and will be buying more. This is a screaming buy under $10 IMO. Could be a fun Thursday and Friday around these parts."

Also thinking they might do either an 8-K(?), or once the SEC filing drops a bunch of Form 3s showing all the => 5/10% OS shareholders Mathias and Kubin et al own that will be way over 10% for several and can not be sold with out an SEC liquidation plan some day.